Laure Croisille

Creteil, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Identification of the Novel HLA-B*57:212 Allele by Next-Generation Sequencing.

Identification of the Novel HLA-B*57:212 Allele by Next-Generation Sequencing.

Journal: HLA
Published: July 10, 2026

Characterisation of the Novel HLA-A*23:163 Allele by Next-Generation Sequencing.

Characterisation of the Novel HLA-A*23:163 Allele by Next-Generation Sequencing.

Journal: HLA
Published: July 10, 2026

Identification of the Novel HLA-DQB1*02:02:41 Allele by Next-Generation Sequencing.

Identification of the Novel HLA-DQB1*02:02:41 Allele by Next-Generation Sequencing.

Journal: HLA
Published: July 09, 2026

Identification of the Novel HLA-DRB1*04:01:26 Allele by Next-Generation Sequencing.

Identification of the Novel HLA-DRB1*04:01:26 Allele by Next-Generation Sequencing.

Journal: HLA
Published: July 03, 2026

Selection of blood products to reduce immunization before HLA-mismatched allogeneic transplantation (SFGM-TC)

Selection of blood products to reduce immunization before HLA-mismatched allogeneic transplantation (SFGM-TC)

Journal: Bulletin du cancer
Published: January 13, 2025

World human neutrophil antigens investigation survey.

World human neutrophil antigens investigation survey.

Journal: Vox sanguinis
Published: May 11, 2023

Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients.

Divergent CD4+ T-cell profiles are associated with anti-HLA alloimmunization status in platelet-transfused AML patients.

Journal: Frontiers in immunology
Published: February 14, 2023

Chronic neutropenia: how best to assess severity and approach management?

Chronic neutropenia: how best to assess severity and approach management?

Journal: Expert review of hematology
Published: September 06, 2021

Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.

Efficacy, safety and immunological profile of combining rituximab with belimumab for adults with persistent or chronic immune thrombocytopenia: results from a prospective phase 2b trial.

Journal: Haematologica
Published: May 18, 2020

New molecular basis associated with CD36-negative phenotype in the sub-Saharan African population.

New molecular basis associated with CD36-negative phenotype in the sub-Saharan African population.

Journal: Transfusion
Published: October 17, 2019

Methylprednisolone-induced immune thrombocytopenia.

Methylprednisolone-induced immune thrombocytopenia.

Journal: American journal of hematology
Published: September 23, 2019

A new platelet alloantigen (Efsa , HPA-35bw) on glycoprotein IIIa leading to neonatal alloimmune thrombocytopenia.

A new platelet alloantigen (Efsa , HPA-35bw) on glycoprotein IIIa leading to neonatal alloimmune thrombocytopenia.

Journal: Transfusion
Published: January 16, 2019
Showing 1-12 of 21

Last Updated: 09/26/2026